Scientist, Process Development Early Phase jobs in United States
cer-icon
Apply on Employer Site
company-logo

Avid Bioservices · 8 hours ago

Scientist, Process Development Early Phase

Avid Bioservices is a leading clinical and commercial biologics CDMO focused on creating innovative solutions to meet the needs of clients and improve patient outcomes. The Scientist, Process Development Early Phase will drive biologics production, support cell culture technologies, and participate in process scale-up and optimization efforts.

BiotechnologyHealth CareMedical
check
H1B Sponsor Likelynote

Responsibilities

Cultivate mammalian and other cell lines for biologics production using various bioreactor systems and cell culture techniques, ensuring strict aseptic conditions
Support activities related to cell line development, including evaluation of cell performance and implementation of strategies to optimize productivity and stability
Contribute to formulation development experiments, assisting in the design and execution of studies to assess product stability, compatibility, and delivery
Conceive and execute well-designed experiments, meticulously analyze results, and derive meaningful insights
Actively engage in supporting both client and internal programs, contributing your expertise to drive successful outcomes
Excel in troubleshooting upstream process issues, proactively brainstorming innovative solutions to overcome upstream challenges
Demonstrate proficiency in operating and troubleshooting essential process equipment, while also pioneering methods and procedures for novel assignments
Maintain comprehensive documentation of data and findings to ensure traceability and regulatory compliance, while regularly updating management on project status and progress
Exhibit strong technical writing skills, creating detailed technical protocols, Process Development reports, guides, SOPs, and other essential documents
Prioritize safety by adhering to all policies, practices, and procedures, promptly reporting any unsafe activities, actively participating in collaborative team efforts to achieve departmental and company goals, and flexibly performing additional duties as assigned
Provide valuable guidance and mentorship to Associate Scientists and Laboratory Assistants, fostering their growth and development
Other tasks as assigned

Qualification

Mammalian cell cultureBioreactor operationProtein productionCGMP complianceTechnical writingMultitaskingTeam collaborationAttention to detail

Required

Bachelor's degree in biology, Biochemistry, Immunology, Virology, or an equivalent scientific field, or a combination of education and experience that demonstrates the necessary knowledge and skills
3+ years of relevant and hands-on experience in protein, or large molecule production
Hands-on experience with various mammalian and other cell lines, adherent and suspension cultures, all executed with stringent aseptic techniques
Proficiency in working with bioreactors for suspension cultures, showcasing practical expertise in this area
Proficiency in working with multi-layer vessels for adherent cultures, demonstrating hands-on experience
Understanding of regulatory requirements and cGMP compliance in bioprocess development

Preferred

Familiarity with microcarriers is desired and will be considered an asset

Benefits

Health, dental, and vision insurance
401(k) matching
Paid time off

Company

Avid Bioservices

twittertwitter
company-logo
Avid Bioservices' expansion will double existing capacity to service both a $40m backlog and its owner Peregrine.

H1B Sponsorship

Avid Bioservices has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (1)
2023 (1)
2022 (5)
2020 (2)

Funding

Current Stage
Public Company
Total Funding
$285M
2024-11-06Private Equity
2024-11-06Acquired
2024-03-06Post Ipo Debt· $160M

Leadership Team

leader-logo
Kenneth Bilenberg
President & Chief Executive Officer
linkedin
Company data provided by crunchbase